Assessing Quality of Life Changes Using Calcitonin in Patients With Hypothyroidism on Biochemical Replacement With Levothyroxine
Phase of Trial: Phase IV
Latest Information Update: 19 Aug 2019
Price : $35 *
At a glance
- Drugs Calcitonin (Primary)
- Indications Hypothyroidism
- Focus Therapeutic Use
- 14 Aug 2019 Status changed from active, no longer recruiting to completed.
- 18 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated